Edited by: Toni P. Miles, Rosalynn Carter Institute for Caregivers, United States
Reviewed by: Mirjam Sophie Rueger, Goethe University Frankfurt, Germany
Liliane D. Efinger, University of Texas at San Antonio, United States
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Bereavement may affect the health of relatives, causing increased use of health care services and increased mortality shortly after the patient's death. However, the long-term consequences for those with a high level of grief symptoms remain largely unexplored. We aimed to investigate associations between grief symptom trajectories and four long-term health outcomes among relatives bereaved by natural death: contacts to general practice and mental health services, use of psychotropic prescription medication, and mortality, over a period of 3–10 years post-bereavement.
We assessed grief symptoms using the Prolonged Grief-13 scale in a cohort of 1,735 bereaved relatives at three different time points (prior to bereavement, 6 months after bereavement, and 3 years after bereavement) and identified five main grief trajectories. The trajectory with persistent low levels of grief symptoms in relatives [n=670 (45%)] was called the low grief trajectory (LGT) and was used as reference. The high grief trajectory (HGT) consisted of 107 (6%) relatives with persistent high grief symptom levels. We investigated associations between grief trajectories and (1) contacts to general practitioner (GP) including out-of-hours using negative binomial regression analysis, (2) contacts to mental health services (GP talk therapy, private-practice psychologist or psychiatrist), (3) use of psychotropic medications (antidepressants, anxiolytics and sedatives) using logistic regression analysis, and (4) mortality using Cox regression analysis. The follow-up period started at 3 years after bereavement and long-term outcome were further followed until 10 years after the patient's death.
Relatives in the HGT had a significantly higher yearly incidence of GP contacts until seven years after bereavement compared to the LGT. The HGT was associated with higher use of mental health services [OR = 2.86 (95%CI 1.58;5.19)], antidepressants [OR = 5.63 (95% CI 3.52; 9.01)], sedatives and anxiolytics [OR = 2.60 (95%CI 1.63;4.14)], and excess mortality [OR = 1.88 (95% CI 1.1;3.2)] compared to the LGT.
This study shows that patients with high and sustained grief symptoms have an increased healthcare use up to 10 years after loss. Future research should assess whether current health care services sufficiently meet the prolonged needs of these relatives.
香京julia种子在线播放
The death of a close relative due to severe illness is a life-changing event for most people. According to the recently developed integrated process model of loss and grief, the death of a significant other is a multidimensional experience causing suffering and may contain both physical, emotional, cognitive, social, and spiritual dimensions (
A large amount of research has been conducted on Prolonged Grief Disorder in recent years and diagnostic criteria have been described (
Mortality in connection with bereavement has been investigated in register-based studies (
Thus, bereavement has been shown to have a long-term impact on bereaved relatives (
In a prior study, we examined the development of relative's grief symptoms based on the Prolonged Grief-13 Scale (
In the present study, we aimed to investigate associations between these grief trajectories and the long-term use of primary healthcare, prescription medication and mental health services, as well as mortality from 3 years up to 10-years after bereavement.
We hypothesized that individuals with high grief symptom levels, especially those in the HGT group, would have a higher use of health care services and higher use of psychotropic medications. The HGT group was vulnerable in prior studies regarding reactions to illness and bereavement and we hypothesized that this group would have a higher mortality compared to the LGT group.
The study is based on a prospective, population-based cohort established in Denmark in 2012 and followed to 2022. The Danish health care system is tax-funded. Services are free of charge for residents, and GPs serve as gate-keepers to secondary care, including palliative care and psychiatric services (
In 2012, we obtained register-based information on all patients receiving drug reimbursement due to terminal illness, i.e. patients with a life-expectancy of only a few weeks or months (
Timeline of exposure (grief trajectories) and register-based outcome variables.
The Prolonged Grief-13 (PG-13) scale (
We have previously identified five specific grief trajectories based on the PG-13 measures at T0, T1, T2 using a semi-parametric group-based trajectory model (GBTM) for repeated measurements (
A unique personal registration number is granted to all Danish citizens. This number allows for linkage between individual-level records in Danish registers and the collected questionnaire data, which was processed at Statistics Denmark.
GP contacts included total daytime contacts (face-to-face, prevention, talk therapy, phone, e-mail, and home visit), daytime face-to-face consultations, and out-of-hours (OoH) initial contacts (phone and video contacts) obtained from the Danish National Health Service Register (
The use of psychotropic medication was measured as registered prescriptions on antidepressants (N06A), sedatives/hypnotics (N05C), or anxiolytics (N05B) according to the Anatomical Therapeutic Chemical (ATC) Classification System obtained from The Danish National Prescription Registry (
Mental health services included GP talk therapy (no, yes), psychotherapy sessions with a private-practice psychologist (no, yes) or private-practice psychiatrist (no, yes) after referral from a GP. The categories (GP talk therapy, psychologist and psychiatrist) were merged due to low numbers in the categories (
We identified bereaved relatives who had died during follow-up. Data on dates of death was retrieved from the Danish Registry of Causes of Deaths (
Information on the age of the relative, gender, educational level according to the UNESCO international standard of classification [low ( ≤ 10 years), intermediate (>10 and ≤ 15 years), high (>15 years)] (
For all the analyses, we described the association between the five grief trajectories and outcome measures with those in the LGT as the reference group. Relatives contributed with at risk time up until date of death, date of emigration or December 31, 2022, whichever came first.
To examine the incidence rate ratios (IRRs) for GP contacts (daytime face-to-face and out-of-hours) according to grief trajectories (LGT as refence) we applied negative binomial regression analyses to account for overdispersion. Repeated yearly measurements were addressed using cluster robust variance estimation (
To examine the odds ratios (ORs) for the dichotomous outcomes mental health contacts and medicine use according to grief trajectories (LGT as reference) we applied logistic regression models. The dichotomous outcomes of mental health contacts and medicine redemptions were analyzed using logistic regression models with follow-up time used as the offset.
Finally, to examine the hazard ratios (HRs) for death according to grief trajectories (LGT as refence) we applied Cox proportional hazards models with age chosen as the underlying time scale. The proportional hazards assumption was assessed graphically using log-minus-log plots and no apparent violation was observed.
The negative binomial regression models yielded incidence rate ratios (IRRs) of yearly GP contacts, the logistic regression models yielded odds ratios (ORs) of medication use and mental health services within the seven-year follow-up period, and the Cox proportional regression model yielded hazard ratios (HRs) of mortality. All regression models were adjusted for the a-priori chosen covariates of age, gender, personal relation to deceased, education and CCI. All estimates were presented with 95% confidence intervals (CIs) and ORs were considered statistically significant if 1 was not included in the CI. All analyses were done using Stata 18 (StataCorp, Texas, USA).
The study population of 1,735 persons included predominantly females (71%). In all, 1,138 were partners (66%), 476 (27%) were adult children and 121 (7%) had another relation to the patient. The mean age was 62 years, 449 (26%) had a low education and 17% had one or more comorbid diseases (CCI≥1) (
Characteristics of the study cohort.
Age, mean (CI*) | 62.0 (61.5; 62.6) |
Male, |
508 (29.3) |
Female, |
1,227 (70.7) |
Partner, |
1,138 (65.6) |
Children, |
476 (27.4) |
Other, |
121 (7.0) |
Low, |
449 (25.9) |
Intermediate, |
828 (47.7) |
High, |
458 (26.4) |
No (CCI = 0), |
1,326 (82.7) |
Yes (CCI ≥ 1), |
278 (17.3) |
*CI, Confidence Interval.
**CCI, Charlson Comorbidity Index.
Relatives in other GT groups than the reference group (LGT) had more GP contacts during the first years of follow-up and the difference seemed to level out toward 10 years of follow-up (
Contacts to general practice during daytime.
Face-to-face contacts to general practice.
Relatives in the HDGT had significantly more total contacts in year five to seven and more face-to-face contacts in year six after bereavement, whereas those in the HGT had significantly more GP daytime contacts (face-to-face contact and total contacts) in year four to seven after bereavement compared to the LGT (
The pattern of initial contact with out-of-hours services showed that in year four after bereavement, the MDGT had significantly more contacts than the LGT, in year five the HDGT had more contacts and in year five and six, the HGT had significantly more contacts than the LGT (
Contacts to general practice out-of-hours.
In the adjusted logistic regression analysis, the HGT was associated with more mental health services [OR = 2.86 (95% CI: 1.58;5.19)], use of antidepressants [OR = 5.63 (95%CI: 3.52;9.01)] and anxiolytics and sedatives [OR = 2.60 (95%CI: 1.63;4.14)] compared to the LGT (
Associations between grief trajectories and use of mental health care and medication.
Low grief trajectory ( |
71 | 4,536 | 1 | - |
Late grief trajectory ( |
14 | 798 | 1.37 | 0.72; 2.6 |
Moderate/decreasing grief trajectory ( |
60 | 3,510 | 1.18 | 0.81;1.74 |
High/decreasing grief trajectory ( |
41 | 2,072 | 1.47 | 0.94; 2.30 |
High grief trajectory ( |
20 | 676 | 2.86 | 1.58;5.19 |
Low grief trajectory ( |
92 | 4,536 | 1 | - |
Late grief trajectory ( |
35 | 798 | 2.46 | 1.53;3.97 |
Moderate/decreasing grief trajectory ( |
77 | 3,510 | 1.04 | 0.74; 1.46 |
High/decreasing grief trajectory ( |
74 | 2,072 | 1.87 | 1.29; 2.70 |
High grief trajectory ( |
52 | 676 | 5.63 | 3.52; 9.01 |
Low grief trajectory ( |
123 | 4,536 | 1 | - |
Late grief trajectory ( |
33 | 798 | 1.59 | 0.99; 2.54 |
Moderate/decreasing grief trajectory ( |
95 | 3,510 | 0.94 | 0.69;1.28 |
High/decreasing grief trajectory ( |
91 | 2,072 | 1.77 | 1.26;2.48 |
High grief trajectory ( |
41 | 676 | 2.60 | 1.63; 4.14 |
aAge, gender, personal relation, education, Charlson Comorbidity Index.
bAccording to an adjusteda logistic regression model with the low grief trajectory as reference.
cGP talk therapy and/or sessions at private-practice psychologist or psychiatrist.
Use of antidepressants was also higher in the LaGT [OR = 2.46 (95% CI: 1.53;3.97)] and HDGT [OR = 1.87 (95%CI: 1.29;2.70)] and use of anxiolytics and sedatives was higher in the HDGT [OR = 1.77 (95%CI: 1.26;2.48)] compared to the LGT (
In total, 186 (10.7%) died during 3–10 years after the patient's death, and the HGT was associated with mortality [OR = 1.88(95%CI: 1.11;3.21)] compared to the LGT (
Associations between grief trajectories and mortality.
Low grief trajectory ( |
49 | 7.3 | 4,536 | 1 | - |
Late grief trajectory ( |
19 | 15.6 | 798 | 1.25 | 0.70; 2.20 |
Moderate/decreasing grief trajectory ( |
54 | 10.3 | 3,510 | 1.20 | 0.80;1.80 |
High/decreasing grief trajectory ( |
41 | 13.2 | 2,072 | 1.51 | 0.98; 2.33 |
High grief trajectory ( |
23 | 21.5 | 676 | 1.88 | 1.11;3.21 |
aAge, gender, personal relation, education, Charlson Comorbidity Index.
bAccording to an adjusteda Cox regression model with the low grief trajectory as reference.
Compared to relatives with a persistent low level of grief symptoms, we found that the grief trajectory groups with higher levels of symptoms had more contact to GP, higher use of mental health care and medication and excess mortality. This was significant for relatives in the HGTs of persistent grief symptoms for all outcome, including contact to GP in the time period until seven years after bereavement. Furthermore, those in the HDGT had a higher use of medication and those in the LaGT had a higher use of antidepressants compared to the LGT.
Bereavement has consistently been associated with increased use of health care and psychotropic medication (
A prior study of health care use before bereavement showed that the HGT was associated with more contacts to GP, medication use, and use of mental health services (
The contact pattern to out-of-hours GP services was diverging. These services are intended for acute situations and available free of charge to all citizens in Denmark (
Regarding psychotropic medication, the use of antidepressant and anxiolytics and sedatives was significantly higher in the HDGT and HGT than in the LGT. Approximately 18% used psychotropic medication in the first year after bereavement (
We found that relatives with HGT had a higher use of any mental health service after bereavement. Hence, the available services seem to be directed at those with the most severe symptoms. However, the persistent need for mental health service over a long-term period could indicate that the existing interventions may not be sufficient to address the needs of bereaved relatives. Also, the vulnerability of the relatives in the HGT group may also be related to prior health and mental health conditions contributing to their need for individually adapted mental health services.
Talk therapy sessions with the GP and private-practice psychologists early in the bereavement period have been found to reduce the risk of suicide, deliberate self-harm, and reduce psychiatric hospitalization in bereaved persons (
We found that relatives with HGT had a higher mortality compared to relatives with LGT. Previous studies did not compare mortality according to symptoms levels, but excess mortality has been found for bereaved compared to non-bereaved persons in most (
The main advantages of the current study are the follow-up time of 10 years, the longitudinal study design of grief symptom assessment at three time points in 1,735 relatives, and the combination with valid register data on health care services. The Danish registers are considered almost complete, and the data can be linked precisely (
The study was limited by the number of participants and thus lacked power to investigate for instance the different types of mental health services. Also, the follow-up of 10 years may be seen as a limitation to reveal long-term impacts of bereavement on mortality. The study included no comparison group from the background population, which was a limitation. Beyond seven years of bereavement, the association of higher use of primary health care in the HGT seemed to level out. This may indicate that the impact of bereavement diminishes over time. However, it could also be due to the group size as a small group of relatives in the HGT could potentially have had many contacts and this effect would diminish if they had died during follow-up.
The study population was younger and had a higher educational level than non-participants (
Despite increased use of health care, including mental health services, those in the HGT had a persistently high level of symptoms. Also, the higher use of medication in the group may indicate a need for further intervention. Bereavement support has been shown to benefit symptomatic persons with psychological distress and need of intervention (
Individuals with elevated grief symptoms were more likely to engage with general practice in the present study. In contrast, a previous study in the US found that relatives with a high grief symptom level underutilized healthcare measured as contacts to the health care system (
To mitigate adverse bereavement reactions, further studies are needed to explore the effects and implementation of targeted intervention in primary care. Such studies should focus on individuals at risk of complications or showing symptoms of distress, such as intensive levels of grief (
In this follow-up study, we found that relatives with persistently high grief symptoms had more frequent contact with primary care up to seven years after bereavement and higher use of psychotropic medication, mental health services and mortality for at least 10 years after bereavement.
These results extend our earlier findings, showing that relatives in the HGT are vulnerable and already have higher primary care use before the patient's death. Moreover, despite seeking mental health care, these relatives continue to use more medication. Thus, the existing interventions may not be sufficient since this group seems to need long-term support. The present findings highlight the need for targeted interventions of long-term support, particularly in primary care, to adequately address the needs of this high-risk group of bereaved relatives.
The datasets presented in this article are not readily available because of GDPR. Requests to access the datasets should be directed to the first author.
The studies involving humans were approved by the Committee on Health Research Ethics of the Central Denmark Region. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
MKN: Investigation, Writing – review & editing, Conceptualization, Methodology, Resources, Funding acquisition, Visualization, Project administration, Validation, Formal analysis, Data curation, Writing – original draft. HP: Writing – review & editing, Software, Formal analysis, Visualization, Data curation, Methodology, Validation, Conceptualization. KS: Writing – review & editing, Funding acquisition, Supervision, Conceptualization, Project administration, Validation, Methodology. MAN: Project administration, Funding acquisition, Writing – review & editing, Methodology, Formal analysis, Validation, Resources, Visualization, Investigation, Conceptualization, Supervision, Data curation. PB: Visualization, Formal analysis, Resources, Data curation, Validation, Methodology, Supervision, Investigation, Conceptualization, Funding acquisition, Writing – review & editing. M-BG: Formal analysis, Writing – review & editing, Supervision, Methodology, Investigation, Visualization, Data curation, Conceptualization, Validation, Funding acquisition, Resources.
The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Novo Nordisk Foundation (grant no. NNF17OC0024410) and the Danish Cancer Society (grant no. R160-A10389-16-S3).
We wish to extend our profound gratitude to patients and relatives who participated in this study. Thanks to the staff at the Research Unit for General Practice, Aarhus, Denmark, in particular data manager Kaare Rud Flarup, and language editor Lone Niedziella. Furthermore, the authors thank statistician Anders Helles Carlsen, Aarhus University Hospital—Psychiatry, Denmark, for his work on grief trajectories.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declare that no Gen AI was used in the creation of this manuscript.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.